These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16188542)

  • 41. Low-dose aspirin before intracranial surgery--results of a survey among neurosurgeons in Germany.
    Korinth MC
    Acta Neurochir (Wien); 2006 Nov; 148(11):1189-96; discussion 1196. PubMed ID: 16969624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What next for low dose aspirin?
    Morgan G
    J Epidemiol Community Health; 2005 Jan; 59(1):3-4. PubMed ID: 15598718
    [No Abstract]   [Full Text] [Related]  

  • 43. Low-dose aspirin and clopidogrel: how to act in patients scheduled for day surgery.
    Servin F
    Curr Opin Anaesthesiol; 2007 Dec; 20(6):531-4. PubMed ID: 17989545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial.
    Giannarini G; Mogorovich A; Valent F; Morelli G; De Maria M; Manassero F; Barbone F; Selli C
    Urology; 2007 Sep; 70(3):501-5. PubMed ID: 17688919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dosage of acetylsalicylic acid in cerebral ischemia].
    Stiegler H
    Internist (Berl); 1997 Mar; 38(3):262-3. PubMed ID: 9173051
    [No Abstract]   [Full Text] [Related]  

  • 46. Safety profile of low-dose aspirin.
    Symmons DP
    Lancet; 1996 Nov; 348(9039):1394-5. PubMed ID: 8937273
    [No Abstract]   [Full Text] [Related]  

  • 47. Papuloerythroderma caused by aspirin.
    Sugita K; Koga C; Yoshiki R; Izu K; Tokura Y
    Arch Dermatol; 2006 Jun; 142(6):792-3. PubMed ID: 16785396
    [No Abstract]   [Full Text] [Related]  

  • 48. Perioperative aspirin therapy in non-cardiac surgery: A systematic review and meta-analysis of randomized controlled trials.
    Wolff G; Navarese EP; Brockmeyer M; Lin Y; Karathanos A; Kołodziejczak M; Kubica J; Polzin A; Zeus T; Westenfeld R; Andreotti F; Kelm M; Schulze V
    Int J Cardiol; 2018 May; 258():59-67. PubMed ID: 29544957
    [No Abstract]   [Full Text] [Related]  

  • 49. [Do antiplatelet agents (aspirin and other antiplatelets such as clopidogrel) increase the risk of hemorrhagic complications after endoscopic polypectomy or endoscopic sphincterotomy and should these drugs therefore be withdrawn 7-10 days before these procedures are performed?].
    Argüello Viudez L
    Gastroenterol Hepatol; 2009 Apr; 32(4):318-20. PubMed ID: 19375822
    [No Abstract]   [Full Text] [Related]  

  • 50. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
    Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
    Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspirin as antiplatelet agent in diabetes. PROS-.
    Davì G; Santilli F
    Eur J Intern Med; 2010 Jun; 21(3):149-53. PubMed ID: 20493412
    [No Abstract]   [Full Text] [Related]  

  • 53. Thirty-day mortality after peptic ulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admission.
    Mose H; Larsen M; Riis A; Johnsen SP; Thomsen RW; Sørensen HT
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):244-50. PubMed ID: 17062325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspirin resistance: is it real? Is it clinically significant?
    Dalen JE
    Am J Med; 2007 Jan; 120(1):1-4. PubMed ID: 17208069
    [No Abstract]   [Full Text] [Related]  

  • 55. Is the management of kidney transplantation influenced by preoperative intake of acetylsalicylic acid?
    Werner W; Klemm A; Wunderlich H; Schubert J
    Urologe A; 1998 Jan; 37(1):102. PubMed ID: 9599183
    [No Abstract]   [Full Text] [Related]  

  • 56. Aspirin for the Primary Prevention of Cardiovascular Disease: Weighing Up the Evidence.
    Murphy S; McCarthy CP; McEvoy JW
    Am J Med; 2019 Sep; 132(9):1007-1008. PubMed ID: 30871925
    [No Abstract]   [Full Text] [Related]  

  • 57. Rebound inflammation and the risk of ischemic stroke after discontinuation of aspirin therapy.
    Pijak MR
    Arch Neurol; 2006 Feb; 63(2):300-1; author reply 301. PubMed ID: 16476829
    [No Abstract]   [Full Text] [Related]  

  • 58. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
    Porter A; Konstantino Y; Iakobishvili Z; Shachar L; Battler A; Hasdai D
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):56-61. PubMed ID: 16763985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
    Wang TH; Bhatt DL; Fox KA; Steinhubl SR; Brennan DM; Hacke W; Mak KH; Pearson TA; Boden WE; Steg PG; Flather MD; Montalescot G; Topol EJ;
    Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Adverse effects of cardiovascular agents in Japan--update 2012].
    Tsukada YT
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():239-44. PubMed ID: 23156515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.